Ó£»¨ÊÓÆµ

Skip to main content

Table 5 OR and 95% CI for changes in SUA for high systolic blood pressure incidence

From: Gender-specific association between serum uric acid levels and hypertension in East China: a cross-sectional study

Ìý

Model 1

Model 2

Model 3

Model 4

Model 5

Variable

OR, 95% CI

P Value

OR, 95% CI

P Value

OR, 95% CI

P Value

OR, 95% CI

P Value

OR, 95% CI

P Value

Males

ÌýÌýÌýÌýÌýÌýÌýÌýÌýÌý

 Q1

1.00 (ref)

-

1.00 (ref)

-

1.00 (ref)

-

1.001

0.0344*

1.07

0.0344*

 Q2

1.00 (0.88, 1.13)

0.9479

1.04 (0.90, 1.19)

0.6172

1.08 (0.94, 1.24)

0.3084

(1.000, 1.001)

(1.01, 1.13)

 Q3

1.03 (0.91, 1.17)

0.6369

1.02 (0.89, 1.16)

0.8275

1.05 (0.91, 1.21)

0.5355

ÌýÌý

 Q4

1.29 (1.14, 1.45)

&±ô³Ù; 0.0001**

1.14 (0.99, 1.31)

0.0608

1.17 (1.01, 1.36)

0.0321*

ÌýÌý

p for trend

&±ô³Ù; 0.0001**

Ìý

0.0862

Ìý

0.0552

ÌýÌýÌýÌýÌý

Female

ÌýÌýÌýÌýÌýÌýÌýÌýÌýÌý

 Q1

1.00 (ref)

-

1.00 (ref)

-

1.00 (ref)

-

1

0.8125

0.99

0.8125

 Q2

1.17 (0.96, 1.42)

0.1259

0.99 (0.80, 1.22)

0.9173

1.04 (0.84, 1.30)

0.7079

(0.999, 1.001)

(0.88, 1.10)

 Q3

1.28 (1.06, 1.56)

0.0125*

0.88 (0.71, 1.09)

0.2289

0.92 (0.74, 1.15)

0.4781

ÌýÌý

 Q4

2.01 (1.68, 2.41)

&±ô³Ù; 0.0001**

0.91 (0.73, 1.12)

0.3529

0.97 (0.78, 1.21)

0.7767

ÌýÌý

p for trend

&±ô³Ù; 0.0001**

Ìý

0.2346

Ìý

0.5467

ÌýÌýÌýÌýÌý

Total

ÌýÌýÌýÌýÌýÌýÌýÌýÌýÌý

 Q1

1.00 (ref)

-

1.00 (ref)

-

1.00 (ref)

-

1.001

0.0022*

1.08

0.0022*

 Q2

1.42 (1.26, 1.60)

&±ô³Ù; 0.0001**

1.01 (0.89, 1.15)

0.8945

1.03 (0.90, 1.17)

0.6689

(1.000, 1.001)

(1.03, 1.14)

 Q3

2.03 (1.81, 2.27)

&±ô³Ù; 0.0001**

1.09 (0.95, 1.25)

0.2252

1.13 (0.99, 1.30)

0.081

ÌýÌý

 Q4

2.54 (2.28, 2.84)

&±ô³Ù; 0.0001**

1.13 (0.98, 1.31)

0.1048

1.18 (1.01, 1.37)

0.0388*

ÌýÌý

p for trend

&±ô³Ù; 0.0001**

Ìý

0.0575

Ìý

0.0196*

ÌýÌýÌýÌýÌý
  1. Notes: Serum uric acid quartiles (Q1–Q4) in men (Q1: ≤ 346.70; Q2: 346.70–395.30; Q3: 395.30–448.70; and Q4: > 448.70 µ mol/L). In women (Q1: ≤ 244.50; Q2: 244.50–281.10; Q3: 281.10–320.80; and Q4: > 320.80 µ mol/L). In total population (Q1: ≤ 278.30; Q2: 278.30–338.60; Q3: 338.60–407.20; and Q4: > 407.20 µ mol/L). BMI, body mass index; FBG, fasting blood glucose; eGFR, estimated glomerular filtration rate; TG, triglycerides; TC, total cholesterol; LDL, low density lipoprotein; HDL, high density lipoprotein
  2. Model 1: Unadjusted
  3. Model 2: Adjusted for age, gender, BMI, FBG, diabetes, TG, TC, LDL, and HDL
  4. Model 3: Adjusted for age, gender, BMI, FBG, diabetes, TG, TC, LDL, HDL, pulse and eGFR
  5. Model 4: Serum uric acid (µ mol/L) as continuous variable. Adjusted for age, gender, BMI, FBG, diabetes, TG, TC, LDL, HDL, pulse and eGFR
  6. Model 5: Serum uric acid (mg/dL) as continuous variable. Adjusted for age, gender, BMI, FBG, diabetes, TG, TC, LDL, HDL, pulse and eGFR
  7. No adjustment for gender in men and women
  8. *P Value < 0.05
  9. **P Value < 0.0001